Evidence map›Paper›PMID 39400814›Full record

ArticleAdvances in experimental medicine and biology2024

Comparison of Eye-Tracking Parameters and Brain Oxygen Saturation in Patients with COVID-19 Moderate Pneumonia.

Alex O Trofimov, Darya I Agarkova, Kseniia A Trofimova, Edwin M Nemoto, Olga A Bragina, Denis E Bragin, Anastasia Medvedeva, Elizabeth Kalinkina

Abstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Advances in experimental medicine and biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alex O TrofimovDepartment of Neurological Diseases, Privolzhsky Research Medical University, Nizhny Novgorod, Russia.
Darya I AgarkovaDepartment of Neurological Diseases, Privolzhsky Research Medical University, Nizhny Novgorod, Russia.
Kseniia A TrofimovaDepartment of Neurological Diseases, Privolzhsky Research Medical University, Nizhny Novgorod, Russia.
Edwin M NemotoDepartment of Neurology, University of New Mexico School of Medicine, Albuquerque, NM, USA.
Olga A BraginaLovelace Biomedical Research Institute, Albuquerque, NM, USA.
Denis E BraginDepartment of Neurology, University of New Mexico School of Medicine, Albuquerque, NM, USA.
Anastasia MedvedevaDepartment of Neurological Diseases, Privolzhsky Research Medical University, Nizhny Novgorod, Russia.
Elizabeth KalinkinaDepartment of Neurological Diseases, Privolzhsky Research Medical University, Nizhny Novgorod, Russia.

Funding

University of New Mexico (UNM) Center for Brain Recovery and RepairP20GM109089 · NIGMS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI SHUTTLEWORTH, CLAUDE W · 2015 to 2024
$22.7M
Brain Injury Treatment by Modulation of Hemodynamics With Blood Soluble Drag Reducing MoleculesR01NS112808 · NINDS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI BRAGIN, DENIS E. · 2019 to 2023
$2.1M
The mechanisms of cerebral microcirculation response to transcranial stimulation.R21AG089266 · NIA · LOVELACE BIOMEDICAL RESEARCH INSTITUTE · PI BRAGINA, OLGA A · 2024 to 2024
$597k
Stroke Treatment by Modulation of Hemodynamics with Drag Reducing MoleculesR21NS091600 · NINDS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI BRAGIN, DENIS E. · 2015 to 2016
$423k
NIA NIH HHS R21 AG089266NIGMS NIH HHS P20 GM109089NINDS NIH HHS R01 NS112808NINDS NIH HHS R21 NS091600
6 · The paper itself

Abstract

The aim was to study the relationship between eye tracking (ET) parameters and cerebral tissue oxygen saturation (SctO MATERIALS AND

methodsA single-centre, non-randomised study included 92 patients in the acute period of SARS-CoV-2 moderate pneumonia (Delta variant). The mean time from admission was 1.5 ± 0.9 days. M:49, W:43. The mean age was 34.7 ± 3.9 years. The eye vergence reactivity index (VRx) was determined using a mobile ET. The cerebral oximetry was performed using Fore-Sight 2030 and included the detection of the SctO

resultsThe calculated vertical VRx was 0.781 ± 0.118. The calculated horizontal VRx was 0.821 ± 0.107. SctO

conclusionsCerebral oxygen saturation in moderate pneumonia caused by the SARS-CoV-2 coronavirus has a significant destabilising effect on the oculomotor synergy (VVRx and HVRx) (p < 0.05).

Indexed as

COVID-19OximetryOxygen SaturationSARS-CoV-2AdultBrainEye MovementsFemaleHumansMaleMiddle AgedOxygenOxygenCerebral oxygenationCOVID-19 pneumoniaEye tracking

Identifiers

PMID39400814
PMCPMC12447872

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.